KRAS and lung cancer: Surprisingly, KRAS mutations, including the G12C variant that can be treated with sotorasib and adagrasib, were identified in the metaplastic bronchiolar epithelium in patients with honeycomb (UIP) lesions, highlighting the pathological continuum from metaplasia to lung cancer in this group of patients [99].